MCRB
Seres Therapeutics, Inc.
Price Chart
No historical data available
Latest Quote
$5.11
+0.16 (+3.23%)
Current Price
| Previous Close | $4.95 |
| Open | $5.00 |
| Day High | $5.14 |
| Day Low | $4.80 |
| Volume | 32,489 |
Stock Information
| Shares Outstanding | 10.04M |
| Total Debt | $56.64M |
| Cash Equivalents | $15.59M |
| Revenue | $1.88M |
| Net Income | $-22.46M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $51.33M |
| EPS (TTM) | $-2.42 |
| Exchange | NMS |
Recent Price History
No history data available. Data will be fetched automatically.
About Seres Therapeutics, Inc.
Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. It also develops SER-603, a LBP candidate optimized to treat disruptions in the GI microbiome and to improve GI mucosal barrier integrity through the inhibition of inflammatory bacteria and associated metabolites; and SER-147, a live biotherapeutic composition to prevent bacterial bloodstream and spontaneous bacterial peritonitis infections in patients with metabolic disease, including chronic liver disease. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
đ° Latest News
No news articles available at the moment. Check back later for updates on MCRB.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $6,544,000 | $3,532,000 | $0 | $0 |
| Cost Of Revenue | $6,544,000 | $3,532,000 | $0 | $0 |
| Total Revenue | $789,000 | $0 | $0 | $0 |
| Operating Revenue | $789,000 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $0 | $0 | $2,468,000 | $6,020,000 |
| Total Expenses | $94,760,000 | $121,315,000 | $195,097,000 | $179,914,000 |
| Other Income Expense | $97,440,000 | $-8,423,000 | $134,000 | $-705,000 |
| Other Non Operating Income Expenses | $16,755,000 | $-14,107,000 | $134,000 | $-705,000 |
| Net Non Operating Interest Income Expense | $2,227,000 | $3,967,000 | $4,833,000 | $-2,962,000 |
| Interest Expense Non Operating | $0 | $0 | $2,468,000 | $6,020,000 |
| Operating Expense | $88,216,000 | $117,783,000 | $195,097,000 | $179,914,000 |
| General And Administrative Expense | $39,156,000 | $53,183,000 | $77,500,000 | $70,263,000 |
| Other Operating Expenses | - | - | $704,000 | $1,004,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $5,696,000 | $-125,771,000 | $-190,130,000 | $-183,581,000 |
| Net Interest Income | $2,227,000 | $3,967,000 | $4,833,000 | $-2,962,000 |
| Interest Income | $2,227,000 | $3,967,000 | $7,301,000 | $3,058,000 |
| Normalized Income | $-74,989,000 | $-131,455,000 | $-190,130,000 | $-183,581,000 |
| Net Income From Continuing And Discontinued Operation | $5,696,000 | $136,000 | $-113,724,000 | $-250,157,000 |
| Total Operating Income As Reported | $-93,971,000 | $-121,315,000 | $-195,097,000 | $-179,914,000 |
| Net Income Common Stockholders | $5,696,000 | $136,000 | $-113,724,000 | $-250,157,000 |
| Net Income | $5,696,000 | $136,000 | $-113,724,000 | $-250,157,000 |
| Net Income Including Noncontrolling Interests | $5,696,000 | $136,000 | $-113,724,000 | $-250,157,000 |
| Net Income Discontinuous Operations | $0 | $125,907,000 | $76,406,000 | $-66,576,000 |
| Net Income Continuous Operations | $5,696,000 | $-125,771,000 | $-190,130,000 | $-183,581,000 |
| Pretax Income | $5,696,000 | $-125,771,000 | $-190,130,000 | $-183,581,000 |
| Special Income Charges | $80,685,000 | $5,684,000 | $0 | $0 |
| Interest Income Non Operating | $2,227,000 | $3,967,000 | $7,301,000 | $3,058,000 |
| Operating Income | $-93,971,000 | $-121,315,000 | $-195,097,000 | $-179,914,000 |
| Gross Profit | $-5,755,000 | $-3,532,000 | $0 | $0 |
| Per Share | ||||
| Diluted EPS | $0.64 | $0.00 | $-17.77 | $-46.20 |
| Basic EPS | $0.64 | $0.00 | $-17.77 | $-46.20 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-70,856,000 | $-125,987,000 | $-181,419,000 | $-170,932,000 |
| Total Unusual Items | $80,685,000 | $5,684,000 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $80,685,000 | $5,684,000 | $0 | $0 |
| Reconciled Depreciation | $4,133,000 | $5,468,000 | $6,243,000 | $6,629,000 |
| EBITDA (Bullshit earnings) | $9,829,000 | $-120,303,000 | $-181,419,000 | $-170,932,000 |
| EBIT | $5,696,000 | $-125,771,000 | $-187,662,000 | $-177,561,000 |
| Diluted Average Shares | $8,869,742 | $7,769,910 | $6,400,339 | $5,403,852 |
| Basic Average Shares | $8,858,975 | $7,769,910 | $6,400,339 | $5,403,852 |
| Diluted NI Availto Com Stockholders | $5,696,000 | $136,000 | $-113,724,000 | $-250,157,000 |
| Gain On Sale Of Business | $80,685,000 | $5,684,000 | $0 | $0 |
| Research And Development | $49,060,000 | $64,600,000 | $117,597,000 | $109,651,000 |
| Selling General And Administration | $39,156,000 | $53,183,000 | $77,500,000 | $70,263,000 |
| Other Gand A | $24,743,000 | $30,504,000 | $77,500,000 | $70,263,000 |
| Salaries And Wages | $14,413,000 | $22,679,000 | $36,629,000 | $31,277,000 |
| Restructuring And Mergern Acquisition | - | - | - | - |
Fetched: 2026-08-31
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $44,218,000 | $13,784,000 | $-44,856,000 | $10,783,000 |
| Total Assets | $138,193,000 | $139,810,000 | $358,600,000 | $348,784,000 |
| Total Non Current Assets | $88,817,000 | $101,136,000 | $183,190,000 | $154,020,000 |
| Other Non Current Assets | $8,699,000 | $8,699,000 | $75,159,000 | $20,051,000 |
| Current Assets | $49,376,000 | $38,674,000 | $175,410,000 | $194,764,000 |
| Other Current Assets | $3,093,000 | $3,130,000 | $8,049,000 | $13,423,000 |
| Receivables | $517,000 | $4,751,000 | $0 | $0 |
| Accounts Receivable | $517,000 | $2,068,000 | $0 | - |
| Cash Cash Equivalents And Short Term Investments | $45,766,000 | $30,793,000 | $127,965,000 | $181,341,000 |
| Cash And Cash Equivalents | $45,766,000 | $30,793,000 | $127,965,000 | $163,030,000 |
| Assets Held For Sale Current | - | $0 | $39,396,000 | - |
| Other Receivables | - | $2,683,000 | - | - |
| Inventory | - | - | $29,647,000 | $0 |
| Investmentin Financial Assets | - | - | - | $0 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $82,966,000 | $91,640,000 | $198,783,000 | $162,590,000 |
| Long Term Debt And Capital Lease Obligation | $72,576,000 | $82,966,000 | $193,196,000 | $158,533,000 |
| Current Debt And Capital Lease Obligation | $10,390,000 | $8,674,000 | $5,587,000 | $4,057,000 |
| Long Term Debt | - | - | $101,544,000 | $50,591,000 |
| Current Debt | - | - | - | $456,000 |
| Other Current Borrowings | - | - | - | $456,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $93,975,000 | $126,026,000 | $403,456,000 | $338,001,000 |
| Total Non Current Liabilities Net Minority Interest | $74,653,000 | $84,804,000 | $304,797,000 | $252,405,000 |
| Other Non Current Liabilities | $2,077,000 | $1,838,000 | $1,628,000 | $1,442,000 |
| Current Liabilities | $19,322,000 | $41,222,000 | $98,659,000 | $85,596,000 |
| Payables And Accrued Expenses | $8,932,000 | $32,548,000 | $26,150,000 | $77,280,000 |
| Payables | $1,682,000 | $4,079,000 | $3,641,000 | $52,210,000 |
| Accounts Payable | $1,682,000 | $4,079,000 | $3,641,000 | $17,440,000 |
| Liabilities Heldfor Sale Non Current | - | $0 | $109,427,000 | - |
| Derivative Product Liabilities | - | $0 | $546,000 | $0 |
| Non Current Deferred Liabilities | - | - | $95,364,000 | $92,430,000 |
| Other Current Liabilities | - | - | $66,922,000 | $34,770,000 |
| Current Deferred Liabilities | - | - | $7,730,000 | $4,259,000 |
| Equity | ||||
| Common Stock Equity | $44,218,000 | $13,784,000 | $-44,856,000 | $10,783,000 |
| Total Equity Gross Minority Interest | $44,218,000 | $13,784,000 | $-44,856,000 | $10,783,000 |
| Stockholders Equity | $44,218,000 | $13,784,000 | $-44,856,000 | $10,783,000 |
| Retained Earnings | $-972,403,000 | $-978,099,000 | $-978,235,000 | $-864,511,000 |
| Gains Losses Not Affecting Retained Earnings | - | - | $0 | $-12,000 |
| Other Equity Adjustments | - | - | - | $-12,000 |
| Other | ||||
| Ordinary Shares Number | $9,556,446 | $8,650,409 | $6,752,073 | $6,261,113 |
| Share Issued | $9,556,446 | $8,650,409 | $6,752,073 | $6,261,113 |
| Tangible Book Value | $44,218,000 | $13,784,000 | $-44,856,000 | $10,783,000 |
| Invested Capital | $44,218,000 | $13,784,000 | $56,688,000 | $61,830,000 |
| Working Capital | $30,054,000 | $-2,548,000 | $76,751,000 | $109,168,000 |
| Capital Lease Obligations | $82,966,000 | $91,640,000 | $97,239,000 | $111,543,000 |
| Total Capitalization | $44,218,000 | $13,784,000 | $56,688,000 | $61,374,000 |
| Additional Paid In Capital | $1,016,611,000 | $991,874,000 | $933,244,000 | $875,181,000 |
| Capital Stock | $10,000 | $9,000 | $135,000 | $125,000 |
| Common Stock | $10,000 | $9,000 | $135,000 | $125,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $72,576,000 | $82,966,000 | $91,652,000 | $107,942,000 |
| Current Capital Lease Obligation | $10,390,000 | $8,674,000 | $5,587,000 | $3,601,000 |
| Current Accrued Expenses | $7,250,000 | $28,469,000 | $22,509,000 | $25,070,000 |
| Net PPE | $80,118,000 | $92,437,000 | $108,031,000 | $133,969,000 |
| Accumulated Depreciation | $-56,613,000 | $-53,196,000 | $-49,078,000 | $-45,040,000 |
| Gross PPE | $136,731,000 | $145,633,000 | $157,109,000 | $179,009,000 |
| Leases | $30,954,000 | $30,954,000 | $32,489,000 | $32,474,000 |
| Construction In Progress | $861,000 | $861,000 | $1,114,000 | $3,970,000 |
| Other Properties | $96,335,000 | $105,371,000 | $115,082,000 | $135,517,000 |
| Machinery Furniture Equipment | $8,581,000 | $8,447,000 | $8,424,000 | $7,048,000 |
| Properties | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | - | - | $95,364,000 | $92,430,000 |
| Current Deferred Revenue | - | - | $7,730,000 | $4,259,000 |
| Dueto Related Parties Current | - | - | $28,053,000 | $34,770,000 |
| Finished Goods | - | - | $0 | $0 |
| Work In Process | - | - | $25,221,000 | $0 |
| Raw Materials | - | - | $4,426,000 | $0 |
| Duefrom Related Parties Current | - | - | $8,674,000 | $0 |
| Other Short Term Investments | - | - | $0 | $18,311,000 |
| Investments And Advances | - | - | - | $0 |
| Available For Sale Securities | - | - | - | - |
Fetched: 2026-08-31
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $865,000 | $-148,989,000 | $-125,329,000 | $-238,637,000 |
| Operating Activities | ||||
| Operating Cash Flow | $1,117,000 | $-148,609,000 | $-117,354,000 | $-228,816,000 |
| Cash Flow From Continuing Operating Activities | $1,117,000 | $-148,609,000 | $-117,354,000 | $-228,816,000 |
| Operating Gains Losses | $-192,000 | $-123,585,000 | $71,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-252,000 | $-380,000 | $-7,975,000 | $-9,821,000 |
| Investing Cash Flow | $-42,000 | $142,293,000 | $10,582,000 | $82,428,000 |
| Cash Flow From Continuing Investing Activities | $-42,000 | $142,293,000 | $10,582,000 | $82,428,000 |
| Net Other Investing Changes | - | $1,401,000 | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $13,167,000 | $23,530,000 | $18,159,000 | $101,168,000 |
| Financing Cash Flow | $13,898,000 | $-90,372,000 | $71,705,000 | $129,602,000 |
| Cash Flow From Continuing Financing Activities | $13,898,000 | $-90,372,000 | $71,705,000 | $129,602,000 |
| Net Common Stock Issuance | $13,167,000 | $23,530,000 | $18,159,000 | $101,168,000 |
| Common Stock Issuance | $13,167,000 | $23,530,000 | $18,159,000 | $101,168,000 |
| Net Other Financing Charges | - | $13,516,000 | - | - |
| Other | ||||
| Repayment Of Debt | $0 | $-127,905,000 | $-52,860,000 | $-1,907,000 |
| Issuance Of Debt | $0 | $0 | $103,378,000 | $27,606,000 |
| Interest Paid Supplemental Data | $0 | $10,858,000 | $12,547,000 | $4,926,000 |
| End Cash Position | $54,434,000 | $39,461,000 | $136,150,000 | $171,215,000 |
| Beginning Cash Position | $39,461,000 | $136,150,000 | $171,215,000 | $188,002,000 |
| Effect Of Exchange Rate Changes | $0 | $-1,000 | $2,000 | $-1,000 |
| Changes In Cash | $14,973,000 | $-96,688,000 | $-35,067,000 | $-16,786,000 |
| Proceeds From Stock Option Exercised | $731,000 | $487,000 | $3,028,000 | $2,735,000 |
| Net Issuance Payments Of Debt | $0 | $-127,905,000 | $50,518,000 | $25,699,000 |
| Net Long Term Debt Issuance | $0 | $-127,905,000 | $50,518,000 | $25,699,000 |
| Long Term Debt Payments | $0 | $-127,905,000 | $-52,860,000 | $-1,907,000 |
| Long Term Debt Issuance | $0 | $0 | $103,378,000 | $27,606,000 |
| Net Investment Purchase And Sale | $0 | $0 | $18,557,000 | $92,249,000 |
| Sale Of Investment | $0 | $0 | $22,983,000 | $140,470,000 |
| Purchase Of Investment | $0 | $0 | $-4,426,000 | $-48,221,000 |
| Net Business Purchase And Sale | $0 | $141,272,000 | $0 | $0 |
| Sale Of Business | $0 | $141,272,000 | $0 | $0 |
| Net PPE Purchase And Sale | $-42,000 | $-380,000 | $-7,975,000 | $-9,821,000 |
| Sale Of PPE | $210,000 | $0 | $0 | - |
| Purchase Of PPE | $-252,000 | $-380,000 | $-7,975,000 | $-9,821,000 |
| Change In Working Capital | $-27,780,000 | $-65,509,000 | $-58,977,000 | $-18,391,000 |
| Change In Other Current Liabilities | $-8,674,000 | $-6,339,000 | $-2,197,000 | $-4,203,000 |
| Change In Payables And Accrued Expense | $-23,377,000 | $-28,844,000 | $4,260,000 | $5,539,000 |
| Change In Accrued Expense | $-20,980,000 | $-25,904,000 | $15,838,000 | $3,336,000 |
| Change In Payable | $-2,397,000 | $-2,940,000 | $-11,578,000 | $2,203,000 |
| Change In Account Payable | $-2,397,000 | $-2,940,000 | $-11,578,000 | $2,203,000 |
| Change In Prepaid Assets | $2,720,000 | $987,000 | $-29,124,000 | $-12,599,000 |
| Change In Inventory | $0 | $-33,795,000 | $-29,647,000 | $0 |
| Change In Receivables | $1,551,000 | $6,606,000 | $-8,674,000 | $0 |
| Changes In Account Receivables | $1,551,000 | $-2,068,000 | $0 | $0 |
| Other Non Cash Items | $8,420,000 | $10,643,000 | $15,168,000 | $6,933,000 |
| Stock Based Compensation | $10,840,000 | $20,971,000 | $34,101,000 | $25,482,000 |
| Asset Impairment Charge | $0 | $3,267,000 | $0 | $0 |
| Amortization Of Securities | $0 | $0 | $-236,000 | $688,000 |
| Depreciation Amortization Depletion | $4,133,000 | $5,468,000 | $6,243,000 | $6,629,000 |
| Depreciation And Amortization | $4,133,000 | $5,468,000 | $6,243,000 | $6,629,000 |
| Depreciation | $4,133,000 | $5,468,000 | $6,243,000 | $6,629,000 |
| Gain Loss On Sale Of PPE | $-192,000 | $317,000 | $0 | $0 |
| Gain Loss On Sale Of Business | $0 | $-146,707,000 | $0 | $0 |
| Net Income From Continuing Operations | $5,696,000 | $136,000 | $-113,724,000 | $-250,157,000 |
| Change In Other Working Capital | - | $-4,124,000 | $6,405,000 | $-7,128,000 |
| Gain Loss On Investment Securities | - | $-546,000 | $-1,554,000 | - |
Fetched: 2026-08-31